This is just a glimpse of the GLP-1 trends available to CivicScience clients. Want to see the full picture? Let’s talk.

CivicScience has data on over 135K GLP-1 users, providing a unique lens into these medications’ societal, cultural, and economic impact. Each month, we deliver key insights into how GLP-1 users are influencing a wide range of industries, including healthcare, retail, food service, fitness, apparel, and travel. Here’s a glimpse of our insights – discover how you can access the full dataset here.

1. Nearly two-thirds say their shopping habits have changed since they began taking a GLP-1 medication for weight loss. 

GLP-1 users are increasingly shifting their clothing preferences, with recent reports highlighting a trend toward smaller, more “edgy” styles. New CivicScience data reveal that nearly one in five users have purchased more clothing or explored different styles since starting a GLP-1 medication. This shift extends beyond style changes, as many users are also trying new brands, experimenting with different types of clothing, and shopping at a wider variety of stores.

2. Trends in alcohol consumption have changed significantly, with wine experiencing the biggest decline.

Alcohol consumption patterns among GLP-1 users are also shifting significantly. CivicScience’s ongoing data reveals that less than half of current users consume at least one alcoholic beverage per week – the lowest point since May 2024. Additionally, consumption trends across beverage types have evolved over the past year, with wine drinking experiencing the steepest decline from Q4 2023 to Q3 2024.

3. A plurality of U.S. adults believe that Medicare and Medicaid should cover weight loss drugs.

The Biden administration recently proposed extending Medicare and Medicaid coverage to include weight loss drugs, sparking a debate as prospective members of Trump’s incoming cabinet express opposing views to GLP-1 medications. CivicScience data reveals that a majority of Americans support Medicare and Medicaid coverage for weight loss medications, with support notably higher among Democrats than among Republicans.

As the GLP-1 landscape evolves, understanding its wide-ranging societal impacts is more important than ever. CivicScience’s GLP-1 consumer data provides invaluable insights into how these medications are transforming consumer behavior and influencing various industries.

Leverage GLP-1 trends impacting your industry.